Balchem Corporation (BCPC) Financial Statements
Balchem Corporation (BCPC) reported trailing twelve-month revenue of $1.1B (up 9.4% year on year) and net income of $170.9M as of 2026-09-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $178.0M.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
BCPCBalchem CorporationFollow BCPC — free
—
Price chart with a free account
- Market cap
- 5.6B
- P/E TTM
- 33.3
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 18 Feb, in 117 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Sep 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.29 | 0.31 | 0.34 | 0.54 | 0.55 | 0.55 | 0.59 | 0.64 | 0.64 | 0.70 | 0.80 | 0.94 | 0.92 | 0.95 | 1.04 | 1.11 | |
| Gross profit | 0.09 | 0.09 | 0.10 | 0.14 | 0.17 | 0.18 | 0.19 | 0.20 | 0.21 | 0.22 | 0.24 | 0.28 | 0.30 | 0.34 | 0.37 | 0.40 | |
| Research & development | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Operating income | 0.06 | 0.06 | 0.07 | 0.08 | 0.09 | 0.09 | 0.10 | 0.11 | 0.10 | 0.11 | 0.13 | 0.15 | 0.16 | 0.18 | 0.21 | 0.23 | |
| Pre-tax income | 0.06 | 0.06 | 0.07 | 0.08 | 0.09 | 0.08 | 0.09 | 0.10 | 0.10 | 0.11 | 0.13 | 0.13 | 0.14 | 0.17 | 0.20 | 0.22 | |
| Income tax | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | -0.00 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | |
| Net income | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 | 0.06 | 0.09 | 0.08 | 0.08 | 0.08 | 0.10 | 0.11 | 0.11 | 0.13 | 0.15 | 0.17 | |
| Diluted EPS ($) | 1.28 | 1.32 | 1.45 | 1.69 | 1.89 | 1.75 | 2.79 | 2.42 | 2.45 | 2.60 | 2.94 | 3.25 | 3.35 | 3.93 | 4.75 | 5.31 | |
| Diluted shares (bn) | 0.030 | 0.030 | 0.031 | 0.031 | 0.032 | 0.032 | 0.032 | 0.032 | 0.033 | 0.033 | 0.033 | 0.032 | 0.032 | 0.033 | 0.033 | — |
USD billions · SEC XBRL
Balchem Corporation — questions
- What is Balchem Corporation's revenue?
- $1.1B over the twelve months to 2026-09-30, up 9.4% year on year, from its 10-Q and 10-K filings.
- What is Balchem Corporation's net income?
- $170.9M over the twelve months to 2026-09-30.
- What is Balchem Corporation's free cash flow?
- $178.0M over the twelve months to 2026-09-30.
- What are Balchem Corporation's diluted earnings per share?
- $5.31 over the twelve months to 2026-09-30.
Every figure on this page comes from Balchem Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.